Viewing nowS.O. Tablets 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 201405108 · Approved 2014.10.31 · Insurance code 649404660
Relief of gastroesophageal reflux and gastrointestinal symptoms; treatment and prevention of ulcers; treatment of Zollinger-Ellison syndrome
This medication is used for long-term maintenance therapy for the treatment of gastroesophageal reflux disease and erosive esophagitis, as well as for alleviation of symptoms in gastroesophageal reflux disease without esophagitis. It is effective when used in combination with antibiotics for the treatment and prevention of recurrence of Helicobacter pylori positive duodenal ulcers and peptic ulcers. It is also used for the treatment of upper gastrointestinal symptoms related to the use of non-steroidal anti-inflammatory analgesics (both non-selective and selective COX-2), and for the treatment and prevention of gastric and duodenal ulcers. Additionally, it is utilized for maintenance therapy to prevent rebleeding due to gastric or duodenal ulcers and for the treatment of Zollinger-Ellison syndrome. In general, it is a medication that helps improve gastrointestinal health and treat related diseases.
This drug should be swallowed with a liquid such as water and should not be chewed or crushed. Adults Gastroesophageal reflux disease (GERD) Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent symptoms may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Concomitant antibiotic therapy for Helicobacter pylori eradication: Administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with nonsteroidal anti-inflammatory drug use (nonselective or selective COX-2 inhibitors): 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. No clinical trials have been conducted for more than 4 weeks. Patients requiring continuous nonsteroidal anti-inflammatory drug treatment Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4–8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. Treatment of Zollinger-Ellison syndrome: The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80–160 mg per day. Doses above 80 mg per day should be divided into 2 doses. Maintenance therapy for 4 weeks following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers: Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. Elderly: No dose adjustment is necessary.
Adolescents 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent symptoms may be controlled by administering 20 mg once daily. Children under 12 years: There is no experience with administering this drug to children under 12 years of age.
This medication should not be used in certain patients. For example, those with allergies to this drug or its components, or those who have experienced hypersensitivity reactions should not take it. Additionally, patients allergic to certain antibiotics, those with specific heart conditions, and nursing women should refrain from taking this medication. This medication contains the pigment Yellow No. 4, so those with allergies or hypersensitivity to this component should use it with caution. When taking this medication, various adverse reactions may occur and caution is needed. For instance, issues related to blood, allergic reactions, neurological symptoms, gastrointestinal problems, skin rashes, etc., have been reported. Especially if symptoms like muscle pain or weakness appear, consult a physician immediately. This medication requires regular check-ups during long-term use, and any changes in symptoms should be discussed with a physician. This medication can interact with other drugs, so if you are taking any other medications, you must inform your doctor or pharmacist. Caution is especially needed when taken alongside certain antibiotics or antiviral medications, and medications that affect blood coagulation. Pregnant women should use this medication cautiously, and it is better for nursing women not to take it. In case of overdose, there is no specific antidote, so it is important to receive symptomatic treatment. This medication must be kept out of reach of children, and transferring it to another container can negatively affect its quality, so caution is advised.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste dysfunction, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distention, allergic reactions, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disturbances, tremor, visual field defects, dysmenorrhea, menstrual disturbances, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric antral polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.
Pale pink round film-coated tablets
28 tablets (14 tablets/PTP X 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.